SCHEDULE 13G - Avalo Therapeutics, Inc. (0001534120) (Subject) | Filings Insight

Avalo Therapeutics, Inc.

0001534120 Nasdaq

SCHEDULE 13G - Avalo Therapeutics, Inc. (0001534120) (Subject)[0]

[SCHEDULE 13G](접수일: 2025-05-15)

[SUBJECT COMPANY]Avalo Therapeutics, Inc. | [FILED BY]Nantahala Capital Management, LLC |

/ 0

SCHEDULE 13G - Avalo Therapeutics, Inc. (0001534120) (Subject) | Filings Insight